VeriTeQ Chairman and CEO Scott R. Silverman to Discuss Company’s
Patented and FDA Cleared Medical Device Identification Technology and
Radiation Dose Measurement Products
DELRAY BEACH, Fla.--(BUSINESS WIRE)--
VeriTeQ Corporation (“VeriTeQ” or “Company”) (OTC Markets: VTEQ), a
provider of implantable medical device identification and radiation dose
measurement technologies, announced today that it will be featured at
the RedChip Emerging Growth Showcase on Wednesday, January 22, 2014.
VeriTeQ’s presentation will air at 12:00 pm ET at http://redchip.com/visibility/investor.asp?symbol=VTEQ&from=confpage31.
VeriTeQ’s Chairman and CEO Scott R. Silverman will discuss VeriTeQ’s FDA
cleared Q Inside Safety Technology, which acts as an electronic serial
number to identify implantable and reusable medical devices to help
ensure the health, safety and wellness of patients. Q Inside Safety
Technology gives physicians and patients access to a secure online
database to retrieve device-specific data such as serial number,
manufacturer name, date of manufacture, lot number, volume, size, and
other data. Q Inside Safety Technology also provides an extra level of
protection to the patient in the event of a recall or other safety
event. Silverman will also discuss the Company’s FDA cleared radiation
dose measurement products, which help prevent radiation overdosing and
under-dosing for patients undergoing radiation therapy treatment.
At the conclusion of his webcast presentation, Silverman will
participate in a live question and answer session.
During the RedChip Emerging Growth Showcase, 25 small-cap company
executives will provide detailed overviews of their businesses through
video presentations and live Q&A sessions. Thousands of investors are
expected to participate. No registration is required to view the event,
which airs between 9:30 a.m. and 4 p.m. ET on January 22-23, 2014 at http://www.RedChip.com.
VeriTeQ develops innovative, proprietary RFID technologies for
implantable medical device identification, and dosimeter technologies
for use in radiation therapy treatment. VeriTeQ offers the world's first
FDA cleared RFID microchip technology that can be used to identify
implantable medical devices, in vivo, on demand, at the point of care.
VeriTeQ's dosimeters provide patient safety mechanisms while measuring
and recording the dose of radiation delivered to a patient in real time.
For more information on VeriTeQ, please visit www.veriteqcorp.com.
Statements in this press release about our future expectations
constitute "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, Section 21E of the Securities
Exchange Act of 1934, and as that term is defined in the Private
Litigation Reform Act of 1995. Such forward-looking statements involve
risks and uncertainties and are subject to change at any time, and our
actual results could differ materially from expected results. These
risks and uncertainties include, without limitation, VeriTeQ’s ability
to commercially launch its Q Inside Safety Technology in the EU in the
first quarter of 2014; the Company’s ability to target the UDI sector
and medical device manufacturers; VeriTeQ’s ability to raise capital; as
well as other risks. Additional information about these and other
factors may be described in VeriTeQ’s Forms 10-Q, filed on August 9,
2013 and November 14, 2013, and future filings with the Securities and
Exchange Commission The Company undertakes no obligation to update or
release any revisions to these forward-looking statements to reflect
events or circumstances after the date of this statement or to reflect
the occurrence of unanticipated events, except as required by law.
Allison Tomek, 561-846-7003
Brendan Hopkins, 1-800-RED-CHIP (733-2447) Ext 134
Source: VeriTeQ Corporation